Mediaboss Marketing

THE EXECUTIVE of an intelligence research lab has visions of programs intertwining with dreams.

The expectations for artificial intelligence in gaming are getting higher as chips and relevant technologies improve at a stunning pace.

1

Midjourney is an AI research lab that bills itself as "expanding the imaginative powers of the human species."

Their products demonstrate the many uses of AI, but CEO David Holz's vision is of programs that do more than turn words into images.

"You'll be able to buy a console with a giant AI chip and all the games will bedreams," Holz told PCGamer.

Easier said than done, but Midjourney's advisors include the CEO of the coding powerhouse Github and the creator of Second Life, one of the first encompassing virtual worlds.

"In theory, the barriers between consuming something and creating something fall away, and it becomes like liquid imagination flowing around the room," Holz continued.

Holz and Midjourney have a roadmap for taking these high-minded, philosophical applications of AI and making them real.

"Everything between now and then is a combination of increasing the quality, being able to do things like 3D, making things faster, making things higher resolution, and having smaller and smaller chips doing more and more stuff."

PCGamer's interview with Holz comes on the heels of a major breakthrough in computer chip development that could enable AI programs to be stored on locally instead of the cloud.

This would make wearables, like VR headsets used for gaming, better suited to run AI programs and taking a step toward AI doing more with a smaller footprint.

There have been flashes of terror over AI's power and Midjourney's own programs spat out a horrifying image when prompted to create the "last selfie ever taken".

Holz addressed the paranoia regarding AI and said "We're not trying to build God, we're trying to amplify the imaginative powers of the human species,"in his discussion with PCGamer.

Holz's dream-generated AI might seem like a long way off, but astechnologygets more advanced, society and industry are better equipped to improve technology faster and more drastically.

Brain-chip companies have begun human trials and Elon Musk tweeted that his brain-chip company Neuralink would have a "progress update show & tell" announcement on October 31

See original here:
Artificial intelligence will soon turn your dreams into video games, expert claims... - The US Sun

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change" report has been added to ResearchAndMarkets.com's offering.

The global artificial intelligence (AI) in drug discovery market reached a value of nearly $791.8 million in 2021, having increased at a compound annual growth rate (CAGR) of 31.0% since 2016. The market is expected to grow from $791.8 million in 2021 to $2,994.5 million in 2026 at a rate of 30.5%. The market is then expected to grow at a CAGR of 25.4% from 2026 and reach $9,293.0 million in 2031.

Growth in the historic period in the artificial intelligence (AI) in drug discovery market resulted from growing adoption of artificial intelligence (AI) for cost efficient drug discovery, growing number of cross-industry collaborations and partnerships, and increasing use of artificial intelligence (AI) for tracking medication adherence. The market was restrained by shortage of skilled labor, challenges due to regulatory changes, low healthcare access, and high rate of AI project failures.

Going forward, rising adoption of cloud-based applications and services, increasing need to control drug discovery & development costs and reduce the overall time, and government initiatives in developing economies will drive market growth. Factors that could hinder the growth of the market in the future include incompatible legacy health IT infrastructure.

North America was the largest region in the artificial intelligence (AI) in drug discovery market, accounting for 44.0% of the total in 2021. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the artificial intelligence (AI) in drug discovery market will be South America and Asia Pacific where growth will be at CAGRs of 40.0% and 37.2% respectively during 2021-2026. These will be followed by Africa and Western Europe, where the markets are expected to register CAGRs of 34.4% and 33.2% respectively during 2021-2026.

The global artificial intelligence (AI) in drug discovery market is concentrated, characterized by the presence of global artificial intelligence (AI) in drug discovery providers. The top ten competitors in the market made up to 50.21% of the total market in 2020. Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.

The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by technology will arise in deep learning segment, which will gain $747.0 million of global annual sales by 2026. The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by drug type will arise in small molecules segment, which will gain $1,287.0 million of global annual sales by 2026.

The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by therapeutic type will arise in other diseases segment, which will gain $480.2 million of global annual sales by 2026. The top opportunities in the artificial intelligence (AI) in drug discovery market segmented by end-users will arise in pharmaceutical companies segment, which will gain $1,028.0 million of global annual sales by 2026. The artificial intelligence (AI) in drug discovery market size will gain the most in the USA at $621.3 million.

Scope

Markets Covered:

1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning

2) By Drug Type: Small Molecule; Large Molecules

3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Respiratory Diseases; Anti-Infective Diseases; Other Therapeutic Areas

4) By End-Users: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes; Others

Key Topics Covered:

1. Artificial Intelligence (AI) In Drug Discovery Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

7. Artificial Intelligence (AI) In Drug Discovery Market Characteristics

8. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

9. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery

10. Global Artificial Intelligence (AI) In Drug Discovery Market Size And Growth

11. Global Artificial Intelligence (AI) In Drug Discovery Market Segmentation

12. Artificial Intelligence (AI) In Drug Discovery Market, Regional And Country Analysis

13. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market

14. Western Europe Artificial Intelligence (AI) In Drug Discovery Market

15. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market

16. North America Artificial Intelligence (AI) In Drug Discovery Market

17. South America Artificial Intelligence (AI) In Drug Discovery Market

18. Middle East Artificial Intelligence (AI) In Drug Discovery Market

19. Africa Artificial Intelligence (AI) In Drug Discovery Market

20. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape

21. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market

22. Artificial Intelligence (AI) In Drug Discovery Market Opportunities And Strategies

23. Artificial Intelligence (AI) In Drug Discovery Market, Conclusions And Recommendations

24. Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/rzodj8

Read this article:
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022: Rising Adoption of Cloud-Based Applications and Services & Need to...

Alphabet and Amazon are among the companies best positioned to take advantage of future artificial intelligence disruption in the technology industry, our analysis shows.

The assessment comes from GlobalDatas Thematic Research ecosystem, which ranks companies on a scale of one to five based on their likelihood to tackle challenges like artificial intelligence and emerge as long-term winners of the technology sector.

According to our analysis, Alphabet, Amazon, Microsoft, Apple, Alibaba, Baidu, ByteDance, Nvidia, Z Holdings, Airbnb, Inspur Electronic, ASML, ABB, Tesla, Siemens, GE, Darktrace, Expedia, Mythic, Alibaba Pictures, Groq, Cerebras, TSMC, Horizon Robotics, UiPath, Automation Anywhere, SambaNova, iFlytek, AMD, Wayfair, Cambricon, Graphcore, Zapata Computing, Cambridge Quantum and Suning.com are the companies best positioned to benefit from investments in artificial intelligence, all of them recording scores of five out of five in GlobalDatas Advertising, Application software, Cloud services, Consumer electronics, Ecommerce, Enterprise security, Industrial automation, IT infrastructure, IT services, Music, Film, & TV, Publishing, Semiconductors, Social media and Telecom infrastructure Thematic Scorecards.

The table below shows how GlobalData analysts scored the biggest companies in the technology industry on their artificial intelligence performance, as well as the number of new artificial intelligence jobs, deals and patents from the companies since August 2021.

The final column in the table represents the overall score given to that company when it comes to their current artificial intelligence position relative to their peers. A score of five indicates that a company is a dominant player in this space, while companies that score less than three are vulnerable to being left behind. These can be read fairly straightforwardly.

The other data points in the table are more nuanced, showcasing recent artificial intelligence investment across a range of areas over the past year. These metrics, where available, give an indication of whether artificial intelligence is at the top of executives minds now, but high numbers in these fields are just as likely to represent desperate attempts to catch-up as they are genuine strength in artificial intelligence.

For example, a high number of deals could either indicate that a company is dominating the market, or that it is using mergers and acquisitions to fill in gaps in its offering.

This article is based on GlobalData research figures as of 19 August 2022. For more up-to-date figures, check the GlobalData website.

Read more:
Revealed: The technology companies leading the way in artificial intelligence - Verdict

Monday 22 August 2022 7:34 am

WITHOUT a doubt, there is vast potential for advancement and benefit to society arising out of the application of artificial intelligence.

Around half of businesses plan to use AI or advanced machine learning in some capacity in the next three years. Transport Secretary Grant Shapps has said self-driving cars could be on our roads as early as next year. This has, predictably, put the debate over artificial intelligence centre stage. What circumstances are cars taught to anticipate? What happens in the event of the unexpected, as often happens on our roads?

There are complex legal, societal and ethical questions to consider. This includes the classic trolley dilemma around who to save when there are choices and how does one stop a robot going rogue?

As AI becomes more common-place, regulators have been seeking to grapple with this and more wide-reaching issues. A major focus for the impending EU Regulation of AI is the need for transparency, fairness and non-bias.

There will also be requirements to report on, with powers for people to be compensated for biased, unethical or incorrect outcomes as well as unfair treatment of data.

When you layer on privacy regulators requirements around how personal data is used the compliance journey for suppliers, adopters and users of AI can be arduous, particularly as new laws emerge and because the laws are and will differ across the world.

Last month, the UK Government set out proposals on the future regulation of AI, calling for people to share their views on the suggested approach. The governments approach is arguably lighter touch than the EU Regulation, aiming to create proportionate and adaptable rules. Both Ofcom and the CMA would be empowered to interpret and implement the key principles.

An ethical approach to the use of AI is not just essential to ensure legal compliance. Potential fines of up to 30,000,000 in the EU, 6 per cent of global turnover and the threat of major reputational damage and erosion of significant value make this a business imperative.

But how can businesses ensure their AI isnt artificially intolerant? Most of it will come down to using the right data and processing it correctly. This is before we even enter the complicated question of whether it is right to use the data, which then leads to a whole set of ethical concerns around fairness.

For example, if the technology is using data from the past as to who has been successful for a role, it could simply lead to unearthing only white male candidates of a certain age, because historically those were the people given most opportunities.

There have already been a number of cases where bias has produced unfair results for example through mortgage applications in non-UK banks. And, of course, the choice as to what decisions an AI system makes for autonomous vehicles and weapons is yet another example of the need to ensure the right guardrails are in place.

At least where systems dont completely think for themselves, some businesses are already grappling with these issues. If they dont theres the potential for reputation damage or even fines.

Boardrooms must understand what the plethora of regulations are going to expect of them and their business and they must prepare a clear action plan including their approach to ethics in technology or corporate social responsibility. Only then can the true potential of AI be unleashed for good without the risk/threat of artificial intolerance or incorrectness..

Read more here:
Artificial intelligence is the new frontier of ethical tests - City A.M.

Today, AI learning requires a connection to a remote server to perform heavy computing calculations. These researchers say changing that could transform health care.

ORLANDO, Fla. Our computers, devices, smart watches, video monitoring systems, etc...- we rely on connectivity to the internet and dont think twice about it. Now, scientists are developing technology for artificial intelligence that will allow it to work even in remote areas.

Self-driving cars, drone helicopters and medical monitoring equipment; its all cutting-edge technology that requires connection to the cloud. Now, researchers at the University of Central Florida are developing devices that wont rely on an internet connection.

What we are trying to do is make small devices, which will mimic the neurons and synapses of the brain, researcher at the University of Central Florida, Tania Roy, PhD, explains.

Right now, artificial intelligence learning requires a connection to a remote server to perform heavy computing calculations. Scientists are making the AI circuits microscopically small.

Roy emphasizes, Each device that we have is the size of 1/100th of a human hair.

The AI can fit on a small microchip less than an inch wide eliminating the need for an internet connection, meaning life-saving devices could work in remote areas. For example, helping emergency responders find missing hikers.

We would send a drone which has a camera eye, and it can just go and locate those people and rescue them, Roy says.

The scientists say with no need for an internet connection, the AI would also work in space, where no AI technology has gone before.

The same UCF team is expanding on their work with artificial brain devices, and they are developing artificial intelligence that mimics the retina in the human eye, meaning someday, AI could instantly recognize the images in front of it. The researchers say this technology is about five years away from commercial use.

If this story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Shelby Kluver at shelby.kluver@wqad.com or Marjorie Bekaert Thomas at mthomas@ivanhoe.com.

Watch more 'Your Health' segments on News 8's YouTube channel

See the article here:
Is the future of artificial intelligence internet-free? These researchers hope so - WQAD Moline